Neurocrine Biosciences, Inc. today announced the appointment of Sanjay Keswani, M.D., to the company's executive management team as Chief Medical Officer (CMO) effective June 2, 2025. Dr. Keswani, an ...
Accomplished physician-scientist brings more than 20 years of industry leadership experience and broad R&D expertise in multiple therapeutic areas SAN DIEGO, April 4, 2025 /PRNewswire/ ...
Biosciences announced the appointment of Sanjay Keswani, M.D., to the company’s executive management team as Chief Medical ...
Barclays analyst Peter Lawson maintained a Buy rating on Arcus Biosciences (RCUS – Research Report) today and set a price target of $29.00. The ...
Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data and AI, presented NeuLogiq® ...
Artis BioSolutions joins a host of startups trying to improve development and manufacturing capacity for cutting-edge gene ...
Trump administration policies on tariffs, renewable energy and electric vehicles are creating uncertainty in the marketplace, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback